Exact Sciences Corporation
Clinical trials sponsored by Exact Sciences Corporation, explained in plain language.
Molecular diagnostics company focused on cancer screening and detection.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Blood test may spot hidden cancer DNA after surgery Results expected May 2027 (estimated)
-
Can a simple blood test spot cancer early? 25,000 volunteers help find out
Diagnosis Recruiting nowThis registry study is testing a blood test designed to detect multiple types of cancer early by looking for DNA and protein changes linked to cancer. Researchers will follow 25,000 people aged 50 to 80 who take the test and any follow-up imaging. The goal is to see how well the …
Sponsor: Exact Sciences Corporation • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
Swab test could spot hidden uterine cancer early
Diagnosis Recruiting nowThis study is collecting vaginal fluid samples from 4,200 people to develop a new test for endometrial cancer. Participants include those with abnormal uterine bleeding or a recent endometrial cancer diagnosis. The goal is to find biomarkers that could lead to a simple, non-invas…
Sponsor: Exact Sciences Corporation • Aim: Diagnosis
Last updated Aug 29, 2026 00:00 UTC
-
Blood test may predict breast cancer return after chemo
Knowledge-focused Recruiting nowThis study is testing a new blood test that looks for tiny bits of tumor DNA to see if it can predict whether high-risk early breast cancer will come back after chemotherapy. About 1,800 people with early-stage breast cancer who are about to start chemo will give blood and tissue…
Sponsor: Exact Sciences Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC